Group President APAC

Director

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Institution	Shares	Value	Change
Vanguard	238,980,083	$4.6B	INCREASED
FMR	157,051,418	$3.0B	INCREASED
BlackRock	150,825,694	$2.9B	INCREASED
State Street	121,619,054	$2.3B	INCREASED
Geode Capital Management	52,021,320	$990M	INCREASED

Insider	Type	Shares	Date
Anindya Dasgupta (Group President APAC)	EXERCISE	16,418	2026-07-31
Richard E Allison JR (Director)	AWARD	1,413	2026-06-29
Smith Jeffrey C (Director)	AWARD	1,413	2026-06-29

Member	Type	Amount	Date
Gilbert Ray Cisneros	SALE	$1,001 - $15,000	2026-07-17
Gilbert Ray Cisneros	SALE	$1,001 - $15,000	2026-07-16
Kevin Hern (Republican)	SALE	$1,001 - $15,000	2026-08-05

Kenvue Inc. (KVUE) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades